Ohio Sleep Medicine Institute | Dublin, OH

Research site

(Unclaimed)

Location

4975 Bradenton Avenue, Dublin, Ohio, United States of America

Site insights

Top conditions

Top treatments

TAK-861

Pitolisant

Tasimelteon

Mazindol

Serdexmethylphenidate

Pramipexole

Sodium Oxybate

SUVN-G3031

Armodafinil

Lemborexant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 32 total trials

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 narcolepsy, who were exposed to previously tested dose...

Enrolling

Narcolepsy Type 1

Drug: TAK-861

A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause (NIRVANA)

Researchers are looking for a better way to treat women who have sleep disturbances associated with menopause.Menopause is part of a natural aging pr...

Active, not recruiting

Sleep Disturbances Associated With Menopause

Other: Placebo

Drug: Elinzanetant

Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM)

A multicenter study to assess the safety and effectiveness of the Genio dual-sided hypoglossal nerve stimulation system for the treatment of obstruct...

Active, not recruiting

Obstructive Sleep Apnea

Device: Genio™ system

eXciteOSA for Treatment of Mild Obstructive Sleep Apnea (OREM)

The objective of this study is to assess the efficacy of the eXciteOSA device amongst a sample of patients with mild OSA. The study is a multi-center...

Active, not recruiting

Sleep Apnea, Obstructive

Device: eXciteOSA

Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obs...

Active, not recruiting

OSA

Drug: AD109

Drug: Placebo

Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

The primary objective of this study is to evaluate the safety and efficacy of pitolisant compared with placebo in treating excessive daytime sleepine...

Active, not recruiting

Myotonic Dystrophy 1

Excessive Daytime Sleepiness

Drug: Pitolisant Oral Tablet

Drug: Placebo oral tablet